Skip to main content

Advertisement

SpringerLink
Log in

Reproductive endocrinology

Don't be so quick to stop hormone-replacement therapy

  • News & Views
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

Finnish women <60 years old have an increased risk of death from cardiac events or stroke within a year of stopping hormone-replacement therapy (HRT), compared with women who have not had HRT and with those on current therapy. The safety of the practice of annual discontinuation of HRT should be questioned.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mikkola, T. S. et al. Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy. J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2015-1864.

  2. Lobo, R. A. Where are we 10 years after the Women's Health Initiative? J. Clin. Endocrinol. Metab. 98, 1771–1780 (2013).

    Article  CAS  Google Scholar 

  3. Stuenkel, C. A. et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2015-2236.

  4. Kaunitz, A. M. & Manson, J. E. Management of menopausal symptoms. Obstet. Gynecol. 126, 859–876 (2015).

    Article  Google Scholar 

  5. Boardman, H. M. P. et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst. Rev. 3, CD002229 (2015).

    Google Scholar 

  6. Lobo, R. A. et al. Prevention of diseases after menopause. Climacteric 17, 540–556 (2014).

    Article  CAS  Google Scholar 

  7. Tuomikoski, P. et al. Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative. Obstet. Gynecol. 124, 947–953 (2014).

    Article  CAS  Google Scholar 

  8. Hulley, S. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280, 605–613 (1998).

    Article  CAS  Google Scholar 

  9. Lobo, R. A. & Clarkson, T. B. Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation. Menopause 18, 237–240 (2011).

    PubMed  Google Scholar 

  10. Berglind, I. A. et al. Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins. Menopause 22, 369–376 (2015).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics & Gynecology, Columbia University, 622 West 168th Street, New York, 10032, New York, USA

    Rogerio Lobo

Authors
  1. Rogerio Lobo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rogerio Lobo.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lobo, R. Don't be so quick to stop hormone-replacement therapy. Nat Rev Endocrinol 12, 11–13 (2016). https://doi.org/10.1038/nrendo.2015.195

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2015.195

  • Springer Nature Limited

This article is cited by

Search

Navigation